• 5-Fluorouracil (5-FU) Toxicity and Chemotherapeutic Response, 5 Mutations
  • Friedreich's ataxia
  • Acute coronary syndrome
  • Prevention of Group B Streptococcal Infection in the Newborn
  • Neuroblastoma
  • Cocaine Metabolites, Urine
  • Polyoma BK Virus, PCR, Quantitative, Plasma
  • Maternal Serum Screen (Quad Screen), Second Trimester
  • Central Nervous System (Meningitis/Encephalitis) Pathogen Panel, Molecular Method
  • Parvovirus B19 Antibody, IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
Medical Test

Turnaround Time
Access to Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism is restricted.
Loading...